Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.

Clinical Trial ID NCT00775281

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00775281

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997 1.85
2 Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 1995 1.39
3 Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 1990 1.25
4 The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J Urol 2001 1.19
5 Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis. J Urol 1992 1.03
6 Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis. Br J Urol 1998 1.01
7 Decreased expression of a glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis. J Urol 1994 0.99
8 Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis. Am J Pathol 2000 0.97
9 Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol 1996 0.89
10 Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis. Urology 1996 0.84
Next 100